These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3446773)

  • 1. Pharmacokinetic study of carbamazepine and its epoxide metabolite in humans.
    Sumi M; Watari N; Umezawa O; Kaneniwa N
    J Pharmacobiodyn; 1987 Nov; 10(11):652-61. PubMed ID: 3446773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
    Konsil J; Dechasathian S; Mason DH; Stevens RE
    J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction effect of phenobarbital on carbamazepine-10,11-epoxide kinetics in the rhesus monkey.
    Wedlund PJ; Patel IH; Levy RH
    J Pharmacokinet Biopharm; 1982 Aug; 10(4):427-35. PubMed ID: 7153873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous plasma carbamazepine and carbamazepine-epoxide concentrations in pharmacokinetic and bioavailability studies.
    Hooper WD; King AR; Patterson M; Dickinson RG; Eadie MJ
    Ther Drug Monit; 1985; 7(1):36-40. PubMed ID: 3992620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
    Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.
    Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A
    Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by erythromycin of the conversion of carbamazepine to its active 10,11-epoxide metabolite.
    Barzaghi N; Gatti G; Crema F; Monteleone M; Amione C; Leone L; Perucca E
    Br J Clin Pharmacol; 1987 Dec; 24(6):836-8. PubMed ID: 3440106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine, with valproate: a pharmacokinetic study.
    Pisani F; Caputo M; Fazio A; Oteri G; Russo M; Spina E; Perucca E; Bertilsson L
    Epilepsia; 1990; 31(3):339-42. PubMed ID: 2111769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study.
    Van Belle K; Sarre S; Ebinger G; Michotte Y
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1217-22. PubMed ID: 7891336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early stage autoinduction of carbamazepine metabolism in humans.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Eur J Clin Pharmacol; 1994; 47(4):355-60. PubMed ID: 7875188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine clearance and seizure stability during pregnancy.
    Johnson EL; Stowe ZN; Ritchie JC; Newport DJ; Newman ML; Knight B; Pennell PB
    Epilepsy Behav; 2014 Apr; 33():49-53. PubMed ID: 24632353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide.
    Tomson T; Tybring G; Bertilsson L
    Clin Pharmacol Ther; 1983 Jan; 33(1):58-65. PubMed ID: 6848300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of valproic acid on metabolic clearance of carbamazepine epoxide.
    Ogiso T; Ito Y; Iwaki M; Horibe Y
    J Pharmacobiodyn; 1990 Apr; 13(4):238-45. PubMed ID: 2143532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 10,11-epoxide-10,11-diol pathway of carbamazepine in early pregnancy in maternal serum, urine, and amniotic fluid: effect of dose, comedication, and relation to outcome of pregnancy.
    Omtzigt JG; Los FJ; Meijer JW; Lindhout D
    Ther Drug Monit; 1993 Feb; 15(1):1-10. PubMed ID: 8451773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
    Rane A; Höjer B; Wilson JT
    Clin Pharmacol Ther; 1976 Mar; 19(3):276-83. PubMed ID: 1261166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postinduction carbamazepine clearance in an adult psychiatric population.
    Martin ES; Crismon ML; Godley PJ
    Pharmacotherapy; 1991; 11(4):296-302. PubMed ID: 1923910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolization of carbamazepine to CBZ-10,11-epoxide in children from the newborn age to adolescence.
    Korinthenberg R; Haug C; Hannak D
    Neuropediatrics; 1994 Aug; 25(4):214-6. PubMed ID: 7824094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy.
    Sachdeo RC; Sachdeo SK; Walker SA; Kramer LD; Nayak RK; Doose DR
    Epilepsia; 1996 Aug; 37(8):774-80. PubMed ID: 8764818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients.
    Patsalos PN
    Br J Clin Pharmacol; 1990 May; 29(5):574-7. PubMed ID: 2350535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.